C12N2750/14251

ERYTHROPARVOVIRUS WITH A MODIFIED CAPSID FOR GENE THERAPY
20250295810 · 2025-09-25 ·

Disclosed are recombinant virions that have a modified capsid protein or a variant thereof of erythroparvovirus and a nucleic acid that includes a heterologous nucleic acid.

ERYTHROPARVOVIRUS COMPOSITIONS AND METHODS FOR GENE THERAPY
20250320521 · 2025-10-16 ·

Disclosed are recombinant virions that have a capsid protein or a variant thereof of erythroparvovirus and a nucleic acid that includes a heterologous nucleic acid.